August 31, 2014 4:54 AM ET

Pharmaceuticals

Company Overview of Sonexa Therapeutics, Inc.

Company Overview

Sonexa Therapeutics, Inc., a pharmaceutical company, engages in the development of therapeutics drugs for the treatment of Alzheimer's disease and related disorders. It develops ST101, a small and orally active molecule compound that penetrates the blood-brain-barrier. The company was incorporated in 2007 and is based in San Diego, California.

12555 High Bluff Drive

Suite 225

San Diego, CA 92130

United States

Founded in 2007

Phone:

858-356-6250

Key Executives for Sonexa Therapeutics, Inc.

Chairman
Age: 64
Chief Financial Officer
Executive Vice President of Research & Development
Senior Vice President of Regulatory Affairs & Quality Assurance
Chief Medical Officer
Age: 63
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
UCB Holdings, Inc. United States
Innocutis Medical, LLC United States
Solmap Pharmaceuticals, Inc. United States
CH Laboratories, Inc. United States
Exemplar Pharma, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Sonexa Therapeutics, Inc., please visit www.sonexa.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.